Centene (STU:QEN) Tariff Resilience Score: 7/10 (As of Jul. 17, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

STU:QEN Centene Corp STU:QEN
74 GF Score
Price €56.02
GF Value €72.21
Valuation Modestly Undervalued
! 7 Warning Signs
View Full Analysis

What is Centene Tariff Resilience Score?

Centene STU:QEN -3.25% 74 Tariff Resilience Score is 7 as of Jul. 17, 2026. GuruFocus rates STU:QEN with a GF Score™ of 74/100 and a GF Value™ of €72.21 (Modestly Undervalued). The stock has 7 warning signs investors should review. Among 18 Healthcare Plans companies, Centene ranks worse than 66.67% on this metric.

Centene has the Tariff Resilience Score of 7, which implies that the company might have Highly Resilient.

Centene has Centene's healthcare services are primarily domestic, reducing direct tariff exposure. However, potential indirect impacts on medical supply costs could pose some risk.

Tariff Resilience Score is a ranking system developed by GuruFocus to measure a company's exposure to international trade tariffs, rated on a scale from 0 to 10. It takes into account key factors such as global supply chain dependencies, manufacturing locations versus sales markets, import / export balance and percentage of revenue, and more.

The company's exposure to international trade tariffs based on these criteria:

1. Global supply chain dependencies
2. Manufacturing locations versus sales markets
3. Import/export balance and percentage of revenue
4. Historical impact from previous tariff changes
5. Available mitigation strategies (alternative suppliers, pricing power)
6. Industry-specific tariff exemptions or vulnerabilities

Based on the research, GuruFocus believes Centene might have Highly Resilient.

Centene  (STU:QEN) Tariff Resilience Score Explanation

The Tariff Resilience Score ranges from 0 to 10, with 10 as the most resilient. GuruFocus divided Moat Score into following 3 categories:

Tariff Resilience Score Resilience Level
7 - 10Highly Resilient
4 - 6Average Resilient
0 - 3Highly Vulnerable

Centene Tariff Resilience Score Related Terms

STU:QEN vs HUM, MOH, OSCR: Tariff Resilience Score Comparison

For the Healthcare Plans subindustry, Centene's Tariff Resilience Score, along with its competitors' market caps and Tariff Resilience Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Centene Tariff Resilience Score vs Healthcare Plans Industry

For the Healthcare Plans industry and Healthcare sector, Centene's Tariff Resilience Score distribution charts can be found below:

* The bar in red indicates where Centene's Tariff Resilience Score falls into.


STU:QEN
74GF Score
Centene Corp STU:QEN
Tariff Resilience Score is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis
What does a Tariff Resilience Score of 7 mean?
Centene (STU:QEN) has a Tariff Resilience Score of 7 as of Jul. 17, 2026. Tariff Score is a ranking system developed by GuruFocus to measure a company's exposure to international trade tariffs, rated on a scale from 0 to 10. It takes into account key factors such as global supply chain dependencies, manufacturing locations versus sales markets, import / export balance and percentage of revenue, and more. According to the industry distribution chart, Centene ranks #12 out of 18 companies in the Healthcare Plans industry, placing it in the top 66.7%.
Is Centene's Tariff Resilience Score too high?
Centene's current Tariff Resilience Score is 7. The Healthcare Plans industry median Tariff Resilience Score is 8.00. Centene's value of 7 is 12.5% below this industry median. Based on the distribution chart, Centene ranks #12 out of 18 companies in the Healthcare Plans industry, which is below the industry midpoint. Overall, Centene has a GF Score™ of 74/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Centene's Tariff Resilience Score compare to HUM and MOH?
According to the Healthcare Plans industry distribution chart, Centene ranks #12 out of 18 companies for Tariff Resilience Score. This places Centene in the lower half of its industry. The industry median Tariff Resilience Score is 8.00. Centene's value of 7 is 12.5% below this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Tariff Resilience Score for a Healthcare Plans company?
The median Tariff Resilience Score among Healthcare Plans companies is 8.00, based on 18 companies in the industry. Companies in the top quartile (top 25%) have a Tariff Resilience Score significantly above this median, while those in the bottom quartile fall well below. However, Tariff Resilience Score should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Centene's current Tariff Resilience Score of 7 is 12.5% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Tariff Resilience Score mean?
A high Tariff Resilience Score can signal that a stock is expensive relative to its fundamentals. Tariff Score is a ranking system developed by GuruFocus to measure a company's exposure to international trade tariffs, rated on a scale from 0 to 10. It takes into account key factors such as global supply chain dependencies, manufacturing locations versus sales markets, import / export balance and percentage of revenue, and more. For the Healthcare Plans industry, the median Tariff Resilience Score is 8.00 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Centene's current Tariff Resilience Score is 7. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Centene stock overvalued right now?
Based on GuruFocus' analysis, Centene (STU:QEN) is currently considered Modestly Undervalued. The stock's GF Value™ is €72.21, compared to a current price of €56.02 — trading 22.4% below its estimated fair value. The current Tariff Resilience Score is 7 and 12.5% below the Healthcare Plans industry median of 8.00. Centene's overall GF Score™ is 74/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Tariff Resilience Score calculated?
Tariff Resilience Score is calculated from a company's financial statements. For Centene (STU:QEN), the current Tariff Resilience Score is 7 as of Jul. 17, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Centene (STU:QEN) Overvalued in 2026?

Based on GuruFocus' analysis, Centene stock appears to be undervalued. The current stock price of €56.02 is trading 22.4% below its estimated GF Value™ of €72.21. GuruFocus considers Centene to be Modestly Undervalued.

Key valuation signals for STU:QEN:

  • Tariff Resilience Score: 7
  • GF Value™: €72.21 vs. price of €56.02 (22.4% below fair value)
  • GF Score™: 74/100 with 7 warning signs
  • Industry Position: 12.5% below the Healthcare Plans median (#12 of 18)

No single metric tells the full story. See the STU:QEN stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Centene Business Description

Address 7700 Forsyth Boulevard, St. Louis, MO, USA, 63105
Centene is a managed care organization that focuses on government-sponsored healthcare plans, including Medicaid, Medicare, and the individual exchanges. Centene served 20 million medical members as of December 2025, mostly in Medicaid (about 64% of membership), the individual exchanges (about 28%), and Medicare (about 5%). The company also provides Medicare Part D pharmaceutical plans.
74GF Score

Get the complete analysis for STU:QEN

Tariff Resilience Score is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€56.02
Price
€72.21
GF Value